EUVIMEDEUVIMED entdecken
Editorial

Ketamine and ECT in Depression — Risks and Rewards

Robert Freedman iD

New England Journal of Medicine · 22.06.2023 · 388 (25) · 2389-2390

DOI: 10.1056/nejme2305130 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 22.06.2023. Verfasst von Robert Freedman. Beteiligte Einrichtung: From the Departments of Psychiatry and Pharmacology, University of Colorado Denver School of Medicine, Aurora. Hauptthemen laut MEDLINE: Depression, Electroconvulsive Therapy, Ketamine, Antidepressive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Investigators from five referral clinics for electroconvulsive therapy (ECT) report in the Journal the results of an open-label, randomized, noninferiority trial of ECT or ketamine infusion in patients with moderately severe depression.1 After randomization, 365 patients (170 in the ECT group and 195 in the ketamine group) were included in the primary analysis. At the conclusion of the 3-week, randomized, active-treatment phase, 41% of the patients in the ECT group and 55% of those in the ketamine group reported a 50% or greater reduction in symptoms, findings that are consistent with moderate-to-excellent responses to treatment.2 Patients who had a response . . .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionElectroconvulsive TherapyKetamineAntidepressive AgentsHumansRewardTreatment Outcome

Substanzen

KetamineAntidepressive Agents

Autor:innen und Institutionen

  • From the Departments of Psychiatry and Pharmacology, University of Colorado Denver School of Medicine, Aurora.

ORCID-Profile: Robert Freedman

Zitieren

APA

Freedman, R. (2023). Ketamine and ECT in Depression — Risks and Rewards. New England Journal of Medicine, 388(25), 2389-2390. https://doi.org/10.1056/nejme2305130

Vancouver

Freedman R. Ketamine and ECT in Depression — Risks and Rewards. New England Journal of Medicine. 2023;388(25):2389-2390. doi:10.1056/nejme2305130

BibTeX
@article{Freedman2023,
  author = {Freedman, Robert},
  title = {Ketamine and ECT in Depression — Risks and Rewards},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {388},
  number = {25},
  pages = {2389--2390},
  doi = {10.1056/nejme2305130}
}
Kostenlos starten →